---
title: >-
  Use of bone-modifying agents among breast cancer patients with bone
  metastasis: evidence from oncology practices in the US.
description: >-
  Explore this publication on real-world evidence: Use of bone-modifying agents
  among breast cancer patients with bone metastasis: evidence from oncology…
date: '2018-01-01'
category: Publications
tags:
  - Clinical Epidemiology
  - Abstract / Manuscript
  - R&D
  - Care
  - Methods/Pharmacoepi
  - Oncology
  - Health System Partner
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/clinical-epidemiology/use-of-bone-modifying-agents-among-breast-cancer-patients/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: use-of-bone-modifying-agents-among-breast-cancer-patients
id: 71vzfsg9y2Cl4f5dRK1BZW
contentType: article
---

## Challenge

Bone-modifying agent use in breast cancer patients with bone metastasis had not been comprehensively characterized in real-world oncology practice, limiting understanding of adherence to evidence-based guidelines.

## Solution

Target RWE researchers analyzed oncology EMR and claims data to characterize bone-modifying agent use across breast cancer patients with bone metastasis, describing real-world utilization patterns and predictors of guideline-concordant therapy.

## Impact

Establishing real-world BMA utilization benchmarks in breast cancer provides oncology drug development partners with contextual evidence needed to position novel agents and identify care gaps representing commercial opportunities.